CMTA is funding researchers at La Jolla Labs, working with John Svaren, PhD, to develop an ASO treatment that increases MFN1 expression as a potential way to compensate for the damaging effects of MFN2 mutations that cause CMT2A.
Simply CMT
More From Simply CMT
-
-
Your Braces Should Be Earning Their Keep: What a New Study Says About AFOs and CMT
In a new study, Dutch researchers found that AFOs can measurably improve how people with CMT walk, but it depends on how the braces are chosen and fitted.